Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company

Please take note that the Board of Directors of the Company in their meeting held today i.e. May 14, 2023, inter-alia, considered and approved the following: 1. Appointment of M/s. S. R. Batliboi & Associates LLP, Chartered Accountants (ICAI Firm Registration No. 101049W/ E300004) as the Statutory Auditors of the Company. 2. Appointment of M/s. Deloitte Touche Tohmatsu India LLP as the Internal Auditors of the Company, for a period of two years i.e., For Financial Year 2023-24 & 2024-25. 3. Re-Appointment of M/s. Ravi & Subramanyam Company Secretaries as the Secretarial Auditors of the Company for the Financial Year 2023 - 24. 4. Re-Appointment of M/s. Lavanya & Associates acted as the Cost Auditors of the Company for the Financial Year 2023-24.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023

Please find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2023.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Dividend Updates

The Board of Directors at their meeting held today May 14, 2023 have recommended payment of final dividend of ? 3/- per Equity Share (@ 30% on a face value of ? 10/- per share) for the Financial Year ended March 31, 2023. The dividend, if approved by the shareholders at the ensuing 25th Annual General Meeting ('AGM') will be dispatched/ credited within 30 days of the AGM.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Annual General Meeting To Be Held On Thursday, June 29, 2023

The Board of Directors at their meeting held today i.e., May 14, 2023, have, inter alia, approved convening of 25th AGM of the Company on Thursday, 29th June, 2023 through video conference or other audio-visual means.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Record Date For The Purpose Of Payment Of Final Dividend For Financial Year 2022-23

Pursuant to Regulation 42 of Listing Regulations, the Board has fixed June 22, 2023 as the Record Date for the purpose of payment of Final Dividend for Financial Year 2022-23 (if approved by the Shareholders at the ensuing AGM).
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Re-Appointment Of Dr. Anil Dhawan (DIN: 08191702) As An Independent Director Of The Company

Re-appointment of Dr. Anil Dhawan (DIN: 08191702) as an Independent Director for another term of 5 consecutive years, commencing from August 30, 2023, subject to approval of the shareholders in the ensuing 25th Annual General Meeting. Dr. Dhawan has confirmed that he is not debarred from holding the office of director by virtue of any Order of SEBI or any other authority. The requisite disclosures as per Regulation 30 of Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed as 'Annexure - A'.
14-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Statement On Deviation Or Variation In Utilisation Of Funds Raised Though Initial Public Offer For The Quarter Ended March 31, 2023

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. CIR/ CFD/CMDl/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended March 31, 2023, there was no deviation or variation in the utilisation of proceeds of the IPO from the objects stated in the Prospectus dated May 2, 2022. A statement of deviation or variation for the quarter ended March 31, 2023, duly reviewed by the Audit Committee of the Company, is enclosed herewith.
14-05-2023
Next Page
Close

Let's Open Free Demat Account